The novel calcineurin inhibitor ISA247 : a more potent immunosuppressant than cyclosporine in vitroBIRSAN, Tudor; DAMBRIN, Camille; FREITAG, Derrick G et al.Transplant international. 2005, Vol 17, Num 12, pp 767-771, issn 0934-0874, 5 p.Article

Renal graft survival and calcineurin inhibitorWOODWARD, Robert S; KUTINOVA, Andrea; SCHNITZLER, Mark A et al.Transplantation. 2005, Vol 80, Num 5, pp 629-633, issn 0041-1337, 5 p.Article

Effect of calcineurin inhibitors on low-density lipoprotein oxidationCOFAN, F; COFAN, M; CAMPOS, B et al.Transplantation proceedings. 2005, Vol 37, Num 9, pp 3791-3793, issn 0041-1345, 3 p.Conference Paper

Excellent results with calcineurin inhibitor-free initial immunosuppression in old recipients of old kidneysBÖSMÜLLER, C; ÖLLINGER, R; MARK, W et al.Transplantation proceedings. 2005, Vol 37, Num 2, pp 881-883, issn 0041-1345, 3 p.Conference Paper

Calcineurin inhibitors in heart transplantationCRESPO-LEIRO, M. G.Transplantation proceedings. 2005, Vol 37, Num 9, pp 4018-4020, issn 0041-1345, 3 p.Conference Paper

CiclosporinePAUL, C; GARAT, H.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 836-838, issn 0151-9638, 3 p.Article

Readministration of Calcineurin Inhibitors for Ulcerative ColitisHIRAOKA, Sakiko; KATO, Jun; SUZUKI, Hideyuki et al.The Annals of pharmacotherapy. 2012, Vol 46, Num 10, pp 1315-1321, issn 1060-0280, 7 p.Article

Understanding the Genetic Basis for Adverse Drug Effects: The Calcineurin InhibitorsBAI, Jane P. F; LESKO, Lawrence J; BURCKART, Gilbert J et al.Pharmacotherapy. 2010, Vol 30, Num 2, pp 195-209, issn 0277-0008, 15 p.Article

La ciclosporine topique: Quand et comment l'utiliser ?MILAZZO, Solange; DRIMBEA, Andrei; JANY, Benjamin et al.Pratiques en ophtalmologie. 2014, Vol 8, Num 76, pp 166-169, issn 2106-9735, 4 p.Article

Calcineurin inhibitors in oral medicineAL JOHANI, Khalid A; HEGARTY, Anne M; PORTER, Stephen R et al.Journal of the American Academy of Dermatology. 2009, Vol 61, Num 5, pp 829-840, issn 0190-9622, 12 p.Article

Innovative Use of Topical Calcineurin InhibitorsLIN, Andrew N.Dermatologic clinics. 2010, Vol 28, Num 3, issn 0733-8635, 535-545, viii [12 p.]Article

Calcineurin-independent inhibition of K_v1.3 by FK-506 (tacrolimus) : a novel pharmacological propertyHYE SOOK AHN; SUNG EUN KIM; KWON, Oh-Joo et al.American journal of physiology. Cell physiology. 2007, Vol 61, Num 5, issn 0363-6143, C1714-C1722Article

The antagonism of calcineurin inhibitors and costimulatory blockers: Fact or fiction?IZAWA, A; SAYEGH, M. H; CHANDRAKER, A et al.Transplantation proceedings. 2004, Vol 36, Num 2S, pp 570S-573S, issn 0041-1345, SUPArticle

Randomized calcineurin inhibitor cross over study to measure the pharmacokinetics of co-administered enteric-coated mycophenolate sodiumKAPLAN, Bruce; MEIER-KRIESCHE, Herwig-Ulf; MINNICK, Paula et al.Clinical transplantation. 2005, Vol 19, Num 4, pp 551-558, issn 0902-0063, 8 p.Article

Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantationALEXANDER, J. Wesley; GOODMAN, Hope R; HANAWAY, Michael et al.Transplant international. 2006, Vol 19, Num 4, pp 295-302, issn 0934-0874, 8 p.Article

The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patientsDAVID-NETO, Elias; LEMOS, Francine C; IANHEZ, Luiz E et al.Transplantation. 2007, Vol 84, Num 1, pp 50-55, issn 0041-1337, 6 p.Article

Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugsARAKI, Motoo; FLECHNER, Stuart M; ISMAIL, Hazem R et al.Transplantation. 2006, Vol 81, Num 3, pp 335-341, issn 0041-1337, 7 p.Article

Proteinuria following a switch from calcineurin inhibitors to sirolimusLETAVERNIER, Emmanuel; PE'RALDI, Marie-Noëlle; PARIENTE, Antoine et al.Transplantation. 2005, Vol 80, Num 9, pp 1198-1203, issn 0041-1337, 6 p.Article

Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitorsNASHAN, Björn.Transplant international. 2004, Vol 17, Num 6, pp 279-285, issn 0934-0874, 7 p.Article

Conversion of stable kidney transplant recipients from a twice daily prograf-based regimen to a once daily modified release tacrolimus-based regimenALLOWAY, R; STEINBERG, S; WISEMANDLE, K et al.Transplantation proceedings. 2005, Vol 37, Num 2, pp 867-870, issn 0041-1345, 4 p.Conference Paper

Immediate conversion from tacrolimus to cyclosporine in the treatment of posttransplantation diabetes mellitusOBERHOLZER, J; THIELKE, J; HATIPOGLU, B et al.Transplantation proceedings. 2005, Vol 37, Num 2, pp 999-1000, issn 0041-1345, 2 p.Conference Paper

Pharmacokinetic differences between morning and evening administration of cyclosporine and tacrolimus therapyIWAHORI, T; TAKEUCHI, H; NAGAO, T et al.Transplantation proceedings. 2005, Vol 37, Num 4, pp 1739-1740, issn 0041-1345, 2 p.Conference Paper

Conversion from cyclosporine to tacrolimus results in improved creatinine but does not alter lipid profileWOODSIDE, K. J; NICHOLS, S. D; HUNTER, G. C et al.Transplantation proceedings. 2005, Vol 37, Num 4, pp 1877-1879, issn 0041-1345, 3 p.Conference Paper

Tacrolimus : In vitro effects on myelopoiesis, apoptosis, and CD11b expressionKOENIG, Joyce M; MATHAROO, Neil; STEGNER, Joseph J et al.The Journal of heart and lung transplantation. 2005, Vol 24, Num 9, pp 1332-1336, issn 1053-2498, 5 p.Article

Conversion of stable liver transplant recipients from a twice-daily prograf-based regimen to a once-daily modified release tacrolimus-based regimenFLORMAN, S; ALLOWAY, R; WISEMANDLE, K et al.Transplantation proceedings. 2005, Vol 37, Num 2, pp 1211-1213, issn 0041-1345, 3 p.Conference Paper